CMC external fixator.

H Klobucar; D Delinar; M Korzinek; K Korzinek

Home/Archive/PubMed

PubMed · 11706716

CMC external fixator.

H Klobucar·D Delinar·M Korzinek·K Korzinek

View original source ↗Export metadata ↓

Abstract

PURPOSE OF THE STUDY: Imobilisation of wounded extremity decreases pain and shock, diminishes the possibilities of soft tissue, vessels and nerves injury with bone fragments, that influences the volume and success of surgical debridement of the wound. Optimal external fixator for war purposes must be rigid in construction, have to be simple to master, allow simple approach to wound during the whole period of fixation, have to be in sterile package with all its necessary part and should not be too expensive. DESIGN OF THE STUDY: Prof. Korzinek in correspondence with "Instrumentarija" from Zagreb developed a new type of external fixateur applicable in war situation and natural disasters. It was named CMC (Croatian Medical Corps) external fixateur, and it ensures imobilisation of extremity during transport to area of final treatment and it could also ensure conditions for definitive fixation. CMC is compound of bar, clamps and Schanz screws. Standard packing are CMC-30 and CMC-40. CONCLUSION: CMC external fixator is the applicable device in war and natural disaster situations. It is simple to master even for less experienced surgeons, it's low volume allows appropriate wound treatment, it could be resterilised and reused and it has acceptable price.

Explore related subjects

Croatia Equipment Design External Fixators Extremities Fracture Fixation Humans Transportation of Patients Warfare Journal Article

Keep this discovery

Explore connections, maps & timelines

BibTeX RIS

H Klobucar, D Delinar, M Korzinek, K Korzinek. 2001. CMC external fixator.. https://pubmed.ncbi.nlm.nih.gov/11706716/

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

PubMed2007

Linkage disequilibria between human leucocyte antigen-B and closely linked microsatellites in the Croatian population.

The aim of the present study was to investigate polymorphism of D6S2927, STR_MICA, D6S2793, TNFa (D6S2792), TNFb and TNFd (D6S2789) microsatellites and linkage disequilibria between these loci and human leucocyte antigen (HLA)-B (previously tested) for better characterisation of extended HLA haplotypes. A total of 176 healthy unrelated Croatians were studied using polymerase chain reaction amplification and electrophoresis on 6% polyacrylamide gel in ALFexpress sequencer. Eight HLA-B/D6S2927 haplotypic associations (B*07/D6S2927-4, B*08/D6S2927-3, B*18/D6S2927-3, B*27/D6S2927-1, B*35/D6S2927-5, B*38/D6S2927-4, B*51/D6S2927-2 and B*61/D6S2927-1) showed strong association (P < 0.001, D > 0.5). Among 88 different HLA-B/STR_MICA haplotypic associations, seven combinations (B*07/STR_MICA-A5.1, B*08/STR_MICA-A5.1, B*15/STR_MICA-A5, B*18/STR_MICA-A4, B*27/STR_MICA-A4, B*38/STR_MICA-A9 and B*51/STR_MICA-A6) demonstrated high linkage (D> or = 0.3) with significant P value (P < 0.001). Strong associations were also observed for five HLA-B/D6S2793 haplotypes (B*07/D6S2793-CA17, B*08/D6S2793-CA24, B*13/D6S2793-CA18, B*14/D6S2793-CA14 and B*27/D6S2793-CA14). HLA-B*08/TNFb3 and HLA-B*50/TNFb7 were the strongest associations for HLA-B/TNFb. Nine HLA-B/TNFa combinations were observed with significant P value (B*07/TNFa11, B*08/TNFa2, B*13/TNFa7, B*18/TNFa10, B*27/TNFa6, B*37/TNFa9, B*38/TNFa10, B*39/TNFa13 and B*44/TNFa4). Out of six HLA-B/TNFd haplotypic associations with strong D value, HLA-B*08/TNFd2 and B*37/TNFd3 showed the highest statistical significance (P < 0.0001). These results provide data on the region around the HLA-B that is very attractive because of its contribution to genetic susceptibility for many HLA-associated diseases and therefore this information will help in all further HLA-B locus-associated disease studies.

Croatia↗

PubMed2006

A new family with the mitochondrial tRNAGLU gene mutation m.14709T>C presenting with hydrops fetalis.

BACKGROUND: In the heterogeneous group of mitochondrial disorders, patients with the same genotype can show different phenotypes and the same phenotype can be caused by different genotypes. We describe a family with the m.14709T>C mutation and a clinical presentation of hydrops fetalis, in contrast to previous reports in which patients presented with myopathy and/or diabetes mellitus. AIM: To identify a mutation in the mtDNA of a family with a heterogeneous clinical presentation. METHODS: Both biochemical and molecular analyses were performed. RESULTS: Biochemical results showed a decreased complex I and IV activity in muscle tissue of the patients. A mosaic-staining pattern for complex I in the patients' fibroblasts was revealed using immunocytochemistry. Molecular analyses identified the m.14709T>C mutation in the mitochondrial encoded tRNA(Glu) gene. CONCLUSION: We report 2 siblings with the m.14709T>C mutation in the mitochondrial tRNA(Glu) gene. The first patient showed hydrops fetalis, a new presentation within the clinical spectrum of this mutation, and the other a known presentation namely mild myopathy.

Croatia↗

PubMed2006

Aseptic meningitis after vaccination with L-Zagreb mumps strain-virologically confirmed cases. Faulty calculation of rates.

In a Letter to the Editor published in Vaccine recently (Vaccine 24 (2006) 6371-6373), the authors describe clinical features of vaccine associated aseptic meningitis (AM) of patients hospitalized in one hospital, proceeding to calculate incidence rates of AM based on hospital admission data. Since the denominator for hospital-based cases is unknown, the incidence rates calculated in such a way are methodologically incorrect and should not be considered relevant.

Croatia↗